DARE Dare Bioscience Inc.

1.24
-0.03  -2%
Previous Close 1.27
Open 1.28
Price To Book 0.89
Market Cap 14163480
Shares 11,422,161
Volume 239,965
Short Ratio 1.02
Av. Daily Volume 524,230

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b trial to be initiated 2H 2018.
SST-6007
Female Sexual Arousal Disorder (FSAD)

Latest News

  1. Daré Bioscience, Inc. Announces Asset Transfer Agreement with Hydra Biosciences, Inc. for CatSper Contraceptive Target
  2. Free Daily Technical Summary Reports on Dermira and Three Other Biotech Stocks
  3. Daré Bioscience, Inc. Expands Leadership Team, Appointing David Friend, Ph.D. to Chief Scientific Officer
  4. DARE: Initiating Coverage of DARE With $6.75/share Price Target
  5. Daré Bioscience, Inc. Expands Leadership Team, Appointing Mary Jarosz, RPh, to Global Head of Regulatory Affairs
  6. Daré Bioscience Inc (NASDAQ:DARE): When Will It Breakeven?
  7. EY Announces that Sabrina Martucci Johnson, CEO of Daré Bioscience, Inc., is an Entrepreneur Of The Year® 2018 Award Finalist in San Diego
  8. Daré Bioscience, Inc. Announces Trial Initiation for Ovaprene® Non-Hormonal Monthly Contraceptive Candidate
  9. Daré Bioscience, Inc. Expands Leadership Team, Appointing John Fair to Chief Business Officer
  10. Daré Bioscience, Inc. Enters into Agreement to Acquire Product to Address Vulvar and Vaginal Atrophy in Hormone Receptor-Positive Breast Cancer Patients
  11. Daré Bioscience announces funding award to further the development of Ovaprene™ from the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  12. Today’s Research Reports on Stocks to Watch: Dare Bioscience and ACADIA
  13. Daré Bioscience, Inc. Enters into Exclusive Worldwide License Agreement for Juniper Pharmaceuticals’ Intravaginal Ring (IVR) Technology Platform
  14. Blog Exposure - BiondVax Pharma Initiated NIH-Sponsored Phase-2 Clinical Trial of M-001 in the US
  15. Dare Bioscience, Inc. to Host Earnings Call